Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; titanium dioxide; lactose monohydrate; gelatin; citric acid; quinoline yellow; magnesium stearate; indigo carmine; dibasic sodium phosphate; sodium lauryl sulfate - significant tumour response to hydroxycarbamide (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

New Zealand - English - Medsafe (Medicines Safety Authority)

devatis limited - hydroxycarbamide 500mg;  ;   - capsule - 500 mg - active: hydroxycarbamide 500mg     excipient: citric acid dibasic sodium phosphate erythrosine gelatin indigo carmine lactose monohydrate magnesium stearate quinoline yellow titanium dioxide - significant tumor response to hydroxycarbamide (hydroxyurea) has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent metastatic or inoperable carcinoma of the ovary. hydroxycarbamide used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.

Malta - English - Medicines Authority

pharmachemic trading agency company limited - hydroxycarbamide - hard capsule - hydroxycarbamide 500 milligram(s) - antineoplastic agents

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - hydroxycarbamide - hard capsule - hydroxycarbamide 500 mg - antineoplastic agents

Kenya - English - Pharmacy and Poisons Board

sandoz gmbh kundl biochemiestrasse 106250, austria - hydroxycarbamide - capsule, hard - 500mg - hydroxycarbamide

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - hydroxycarbamide - oral capsule - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - hydroxycarbamide - oral capsule - 500mg

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - hydroxycarbamide (hydroxyurea), quantity: 500 mg - capsule, hard - excipient ingredients: indigo carmine; dibasic sodium phosphate heptahydrate; magnesium stearate; titanium dioxide; citric acid; lactose monohydrate; iron oxide yellow; gelatin; erythrosine; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - significant tumour response to hydrea has been demonstrated in, chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent, metastatic, or inoperable carcinoma of the ovary.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

medac gmbh - hydroxycarbamide - capsules - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - hydroxycarbamide - tablet - 1gram